Refresh

Orchid Pharma Ltd. - Research Center

524372 ORCHPHARMA Group (B) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Sales

665.90 556.97 450.70 505.45 583.65

Operating profit

83.62 57.26 57.89 -44.26 -12.69

Interest

32.23 32.01 51.34 4.16 0.30

Gross profit

70.82 34.25 13.03 -23.94 3.94

EPS (Rs)

13.28 -1.18 -28.70 -16.84 -11.36
Annual  results in details
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Other income

19.43 9.00 6.48 24.49 16.93

Stock adjustment

-21.48 -22.73 -15.69 5.83 20.43

Raw material

406.10 336.80 244.96 234.24 257.43

Power and fuel

- - - - -

Employee expenses

65.35 60.21 64.40 81.48 79.14

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

132.31 125.44 99.14 228.16 239.33

Provisions made

- - - - -

Depreciation

54.79 87.02 108.90 125.90 129.92

Taxation

- - - - -

Net profit / loss

54.19 -4.81 -117.15 -149.84 -101.05

Extra ordinary item

38.15 47.96 -21.28 - 24.94

Prior year adjustments

- - - - -

Equity capital

40.82 40.82 40.82 88.96 88.96

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

12.56 10.28 12.84 -8.76 -2.17

GPM (%)

10.33 6.05 2.85 -4.52 .66

NPM (%)

7.91 -0.85 -25.63 -28.27 -16.83
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com